BioSpace News Archive

Sanjeev Luther, president and chief executive officer of Rafael Pharmaceuticals, told BioSpace that the company made the decision to continue to enroll the trial, which was 75% filled, due to the short timeline patients with metastatic pancreatic cancer have.

Here’s a look at what’s on the U.S. Food and Drug Administration’s schedule for the next two weeks.

Despite the poor Q1 economic data that is beginning to be released, the equity markets are stabilizing.

Hutchison China MediTech Limited announces that the U.S. Food and Drug Administration has granted two Fast Track Designations for the development of surufatinib, for the treatment of both advanced and progressive pancreatic neuroendocrine tumors and extra-pancreatic NET in patients who are not amenable for surgery.

The presence of multiple players has fragmented the Latin America pharmaceutical products and CMO market.

The injectable route of administration is quite common for faster delivery of drugs and medication.

The presence of a large number of players renders high fragmentation in the global patient monitoring and ultrasound devices display market, says Transparency Market Research in a new report.

The global market for gold nanoparticles is highly competitive and is considered as consolidated in nature, owing to the presence of a few local and global players operating worldwide, states a new market intelligence study by Transparency Market Research.

The consequences of lifestyle diseases are aplenty. One condition like obesity, hypertension, or diabetes which are also result of stress, can be dangerous to the entire body.

Need for smarter and smaller sensors will dominate the global body sensor market between 2017 and 2022.